Suppresses absorption of Vitamin B6. This medication is commonly used for High Cholesterol
Research demonstrates that fibrates, particularly fenofibrate, are known to increase homocysteine levels. Elevated levels of homocysteine is associated with increased risk of a range of health problems including atherosclerosis, stroke, and neurological diseases, and vitamin Bs including vitamin B6 helps facilitate the breakdown of homocysteine and may be helpful in reducing homocysteine levels.
Foucher C, Brugère L, Ansquer JC. Fenofibrate, homocysteine and renal function. Curr Vasc Pharmacol. 2010 Sep;8(5):589-603. J Dierkes et al.Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate. Atherosclerosis. 2001 Sep;158(1):161-4. doi: 10.1016/s0021-9150(00)00766-8. Jutta Dierkes et al. Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels. Vasc Health Risk Manag. 2007;3(1):99-108.
B6 Blend {Pyridoxine HCl + Pyridoxal -5-Phosphate (P5P) — 5mg
Low vitamin B6 status can promote accumulation of homocysteine, a sulfur‑containing amino acid that can damage the endothelium, increase oxidative stress, and promote clot formation, all of which are relevant to cardiovascular disease and stroke. Large observational studies and cross‑sectional analyses have shown that people with lower plasma pyridoxal‑5‑phosphate (active B6) levels have higher rates of stroke and other vascular events, and in some cohorts low B6 was a stronger predictor of stroke or transient ischemic attack than homocysteine itself. The encouraging finding from meta‑analyses and clinical trials is that B‑vitamin combinations including B6 can lower homocysteine and modestly reduce the combined risk of stroke, myocardial infarction, and vascular death in high‑risk patients, suggesting that maintaining adequate B6 is one useful piece of broader cardiovascular prevention
In the brain, vitamin B6 (pyridoxine) is needed to produce neurotransmitters and to keep homocysteine in check, so low B6 status has been linked to both depressed mood and subtle cognitive problems such as slower processing and poorer attention in some adults. Observational work in older populations suggests that lower blood levels or intakes of B6 tend to track with worse performance on memory, executive‑function, and psychomotor‑speed tests, raising concern that marginal B6 status may contribute to age‑related cognitive decline. Clinically, when B6 deficiency coexists with depression, correcting it is viewed as one modifiable factor that may help support clearer thinking and better cognitive function alongside standard psychiatric and lifestyle treatments.
In the nervous system, vitamin B6 is essential for making the inhibitory neurotransmitter GABA, so significant deficiency can lower seizure threshold and lead to seizures or encephalopathy, particularly in infants but occasionally in adults. Classic pyridoxine‑dependent or B6‑responsive seizure syndromes in infants often present with refractory seizures that improve dramatically after B6 or pyridoxal‑5‑phosphate is given, highlighting how crucial this pathway is for brain stability. Clinically, this means that in patients, especially infants, with otherwise unexplained or treatment‑resistant seizures or encephalopathy, assessing and correcting B6 status is a low‑risk, potentially lifesaving step that should be considered early.
Vitamin B6 (50% Pyridoxine and 50% P-5-P) by Pure Encapsulations — 10 mg